Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Maria Tiziana Corasaniti, Giacinto Bagetta, Pierluigi Nicotera, et al.
Toxins (2023) Vol. 15, Iss. 5, pp. 332-332
Open Access | Times Cited: 12

Showing 12 citing articles:

BoNT/Action beyond Neurons
Sara Marinelli
Toxicon (2025), pp. 108250-108250
Closed Access | Times Cited: 1
Comparative Long-Term Effectiveness Of OnabotulinumtoxinA (Botox) And Anti CGRP In Migraine Prevention: A Systematic Review
Elizabeth Gaviria, Awab Hamid Eltayeb Hamid
F1000Research (2024) Vol. 13, pp. 665-665
Open Access | Times Cited: 1
Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis
Chengqi Zhao, Changxin Li, Xueping Yu, et al.
Journal of Neurology (2024) Vol. 271, Iss. 9, pp. 5762-5777
Closed Access | Times Cited: 1
The safety and efficacy of onabotulinumtoxinA injections for children and adolescents with chronic migraine: A systematic review and meta‐analysis
R. Bruce Lindsay, Amira Kalifa, Jonathan W. P. Kuziek, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 10, pp. 1200-1216
Open Access | Times Cited: 1
Comprehensive list of preventative migraine headache medications without significant drug–drug interactions
Jay Dave, Ian Hakkinen, Pengfei Zhang
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Botulinum toxin injection for migraine and other headache disorders
Moises Dominguez, Sait Ashina, Cyrus Yazdi, et al.
Elsevier eBooks (2024), pp. 11-25
Closed Access
Botulinum toxin is a new drug for the treatment of migraine
M. I. Lastovetska, I. O. Mudryk, V. P. Maslii, et al.
Reports of Vinnytsia National Medical University (2024) Vol. 28, Iss. 4, pp. 755-759
Open Access
Efficacy and Safety Analysis of Botox Application and Iatrogenic Botulism: Panacea or Peril?
Özgür Karcıoğlu, Canan Akman, Ilknur Atnis
Current Pharmaceutical Design (2024) Vol. 30, Iss. 8, pp. 578-588
Closed Access
Subjective Discomfort during Botulinumtoxin Injections Dependent on Injection Site and Needle Size: A Comparison Between 30G, 33G and 34G Needles
Till Kämmerer, Randolf Bertlich, Daniela Hartmann, et al.
Aesthetic Plastic Surgery (2024) Vol. 48, Iss. 13, pp. 2528-2535
Open Access
Is Botulinum Toxin Treatment Safe?
Bahman Jabbari
Springer eBooks (2024), pp. 285-292
Closed Access
The effectiveness and predictors influencing the outcome of onabotulinumtoxinA treatment in chronic migraine: understanding from diverse patient profiles in a single session
Elif Ilgaz Aydınlar, Tuba Erdoğan Soyukibar, Pınar Yalinay Dikmen
Frontiers in Neurology (2024) Vol. 15
Open Access
The Potential Therapeutic Effects of Botulinum Neurotoxins on Neoplastic Cells: A Comprehensive Review of In Vitro and In Vivo Studies
Delaram Safarpour, Fattaneh A. Tavassoli, Bahman Jabbari
Toxins (2024) Vol. 16, Iss. 8, pp. 355-355
Open Access
Page 1

Scroll to top